Vmbook Online ordering

Genethera Inc

I am a helpful assistant and while I do not have real-time access to specific stock market data or databases, I can certainly help you with general information about a public company.

GeneTx Biotherapeutics LLC, not Genethera Inc., is a company that commonly appears in biotechnology listings. It is a clinical-stage company that focuses on the development of gene therapy solutions for the treatment of genetic diseases, specifically Fragile X Syndrome. It is not a publicly traded company, but a subsidiary of Ultragenyx Pharmaceutical Inc. (RARE), which is a publicly traded company on the Nasdaq stock exchange.

GeneTx Biotherapeutics was established as a result of a collaboration between Ultragenyx and scientific research groups from the University of Texas Southwestern Medical Center and the University of California, San Diego.

For up-to-date and accurate information about the company, its financials, and stock performance, it is best to visit the SEC's EDGAR database, the company's official website, or financial news and data platforms such as Nasdaq, Yahoo Finance, or Bloomberg. If Genethera Inc. is indeed a different company, I recommend searching these resources for accurate information related to that specific entity.